Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies
Renal allograft thrombosis can cause transplant failure. Because antiphospholipid antibodies (aPA) are associated with thrombosis, we investigated pretransplant sera from patients with early renal allograft failure to determine if aPA were present. Fifty-six final cross-match (FxM) sera from patient...
Gespeichert in:
| Veröffentlicht in: | Transplant international 2000, Vol.13 Suppl 1, p.S78-S81 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S81 |
|---|---|
| container_issue | |
| container_start_page | S78 |
| container_title | Transplant international |
| container_volume | 13 Suppl 1 |
| creator | Wagenknecht, D R Fastenau, D R Torry, R J Becker, D G LeFor, W M Carter, C B Haag, B W McIntyre, J A |
| description | Renal allograft thrombosis can cause transplant failure. Because antiphospholipid antibodies (aPA) are associated with thrombosis, we investigated pretransplant sera from patients with early renal allograft failure to determine if aPA were present. Fifty-six final cross-match (FxM) sera from patients whose transplant failed within 16 days were compared to FxM sera from the next sequential transplant patients. The sera were tested for IgG, IgM, and IgA antibodies to cardiolipin, phosphatidylserine, and phosphatidylethanolamine. aPA were identified in 57% of FxM sera from patients with early non-function versus 35% of FxM sera from patients with functioning grafts (P = 0.02). Historical sera from 11 aPA-positive patients contained aPA up to 18 months prior to transplantation. Since aPA were present in historical sera, testing for aPA can identify certain patients at risk for early allograft failure. The involvement of aPA in early allograft loss is supported by studies demonstrating aPA recovery from an explanted failed transplant. |
| doi_str_mv | 10.1007/s001470050280 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72472358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72472358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1367-ec8db3ee7bd1c55852a93bee3d222d2bb595c68d41d4a66951b9ecf438e31a3d3</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMotlaXbiUrd6N5TmaWUnxBQRBdj3ncsdF0MiYzSP-9rS2IBy4HLh9n8SF0TskVJURdZ0KoUIRIwipygKZUcFYwptQhmpKai4JUSkzQSc4fhGwYSY7RhG5Tl2qK3p59_sSxxaBTWOMEnQ5YhxDfk24H3GofxgTYZ-w7m0BncLiNCfd68NANGX_7YYl1N_h-GfPmgu-9-32Y6DzkU3TU6pDhbN8z9Hp3-zJ_KBZP94_zm0VhKS9VAbZyhgMo46iVspJM19wAcMcYc8wYWUtbVk5QJ3RZ1pKaGmwreAWcau74DF3udvsUv0bIQ7Py2UIIuoM45kYxoRiX1QYsdqBNMecEbdMnv9Jp3VDSbJU2_5Ru-Iv98GhW4P7ovUP-A4UJcrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72472358</pqid></control><display><type>article</type><title>Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Wagenknecht, D R ; Fastenau, D R ; Torry, R J ; Becker, D G ; LeFor, W M ; Carter, C B ; Haag, B W ; McIntyre, J A</creator><creatorcontrib>Wagenknecht, D R ; Fastenau, D R ; Torry, R J ; Becker, D G ; LeFor, W M ; Carter, C B ; Haag, B W ; McIntyre, J A</creatorcontrib><description>Renal allograft thrombosis can cause transplant failure. Because antiphospholipid antibodies (aPA) are associated with thrombosis, we investigated pretransplant sera from patients with early renal allograft failure to determine if aPA were present. Fifty-six final cross-match (FxM) sera from patients whose transplant failed within 16 days were compared to FxM sera from the next sequential transplant patients. The sera were tested for IgG, IgM, and IgA antibodies to cardiolipin, phosphatidylserine, and phosphatidylethanolamine. aPA were identified in 57% of FxM sera from patients with early non-function versus 35% of FxM sera from patients with functioning grafts (P = 0.02). Historical sera from 11 aPA-positive patients contained aPA up to 18 months prior to transplantation. Since aPA were present in historical sera, testing for aPA can identify certain patients at risk for early allograft failure. The involvement of aPA in early allograft loss is supported by studies demonstrating aPA recovery from an explanted failed transplant.</description><identifier>ISSN: 0934-0874</identifier><identifier>EISSN: 1432-2277</identifier><identifier>DOI: 10.1007/s001470050280</identifier><identifier>PMID: 11111967</identifier><language>eng</language><publisher>England</publisher><subject>Antibodies, Antiphospholipid - blood ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoglobulin A - blood ; Immunoglobulin G - blood ; Immunoglobulin M - blood ; Kidney Transplantation - immunology ; Kidney Transplantation - physiology ; Postoperative Period ; Renal Dialysis ; Retrospective Studies ; Risk Factors ; Treatment Failure ; Treatment Outcome</subject><ispartof>Transplant international, 2000, Vol.13 Suppl 1, p.S78-S81</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1367-ec8db3ee7bd1c55852a93bee3d222d2bb595c68d41d4a66951b9ecf438e31a3d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11111967$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wagenknecht, D R</creatorcontrib><creatorcontrib>Fastenau, D R</creatorcontrib><creatorcontrib>Torry, R J</creatorcontrib><creatorcontrib>Becker, D G</creatorcontrib><creatorcontrib>LeFor, W M</creatorcontrib><creatorcontrib>Carter, C B</creatorcontrib><creatorcontrib>Haag, B W</creatorcontrib><creatorcontrib>McIntyre, J A</creatorcontrib><title>Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies</title><title>Transplant international</title><addtitle>Transpl Int</addtitle><description>Renal allograft thrombosis can cause transplant failure. Because antiphospholipid antibodies (aPA) are associated with thrombosis, we investigated pretransplant sera from patients with early renal allograft failure to determine if aPA were present. Fifty-six final cross-match (FxM) sera from patients whose transplant failed within 16 days were compared to FxM sera from the next sequential transplant patients. The sera were tested for IgG, IgM, and IgA antibodies to cardiolipin, phosphatidylserine, and phosphatidylethanolamine. aPA were identified in 57% of FxM sera from patients with early non-function versus 35% of FxM sera from patients with functioning grafts (P = 0.02). Historical sera from 11 aPA-positive patients contained aPA up to 18 months prior to transplantation. Since aPA were present in historical sera, testing for aPA can identify certain patients at risk for early allograft failure. The involvement of aPA in early allograft loss is supported by studies demonstrating aPA recovery from an explanted failed transplant.</description><subject>Antibodies, Antiphospholipid - blood</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Humans</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin M - blood</subject><subject>Kidney Transplantation - immunology</subject><subject>Kidney Transplantation - physiology</subject><subject>Postoperative Period</subject><subject>Renal Dialysis</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Treatment Failure</subject><subject>Treatment Outcome</subject><issn>0934-0874</issn><issn>1432-2277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLAzEUhYMotlaXbiUrd6N5TmaWUnxBQRBdj3ncsdF0MiYzSP-9rS2IBy4HLh9n8SF0TskVJURdZ0KoUIRIwipygKZUcFYwptQhmpKai4JUSkzQSc4fhGwYSY7RhG5Tl2qK3p59_sSxxaBTWOMEnQ5YhxDfk24H3GofxgTYZ-w7m0BncLiNCfd68NANGX_7YYl1N_h-GfPmgu-9-32Y6DzkU3TU6pDhbN8z9Hp3-zJ_KBZP94_zm0VhKS9VAbZyhgMo46iVspJM19wAcMcYc8wYWUtbVk5QJ3RZ1pKaGmwreAWcau74DF3udvsUv0bIQ7Py2UIIuoM45kYxoRiX1QYsdqBNMecEbdMnv9Jp3VDSbJU2_5Ru-Iv98GhW4P7ovUP-A4UJcrw</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Wagenknecht, D R</creator><creator>Fastenau, D R</creator><creator>Torry, R J</creator><creator>Becker, D G</creator><creator>LeFor, W M</creator><creator>Carter, C B</creator><creator>Haag, B W</creator><creator>McIntyre, J A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies</title><author>Wagenknecht, D R ; Fastenau, D R ; Torry, R J ; Becker, D G ; LeFor, W M ; Carter, C B ; Haag, B W ; McIntyre, J A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1367-ec8db3ee7bd1c55852a93bee3d222d2bb595c68d41d4a66951b9ecf438e31a3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Antibodies, Antiphospholipid - blood</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Humans</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin M - blood</topic><topic>Kidney Transplantation - immunology</topic><topic>Kidney Transplantation - physiology</topic><topic>Postoperative Period</topic><topic>Renal Dialysis</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Treatment Failure</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wagenknecht, D R</creatorcontrib><creatorcontrib>Fastenau, D R</creatorcontrib><creatorcontrib>Torry, R J</creatorcontrib><creatorcontrib>Becker, D G</creatorcontrib><creatorcontrib>LeFor, W M</creatorcontrib><creatorcontrib>Carter, C B</creatorcontrib><creatorcontrib>Haag, B W</creatorcontrib><creatorcontrib>McIntyre, J A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wagenknecht, D R</au><au>Fastenau, D R</au><au>Torry, R J</au><au>Becker, D G</au><au>LeFor, W M</au><au>Carter, C B</au><au>Haag, B W</au><au>McIntyre, J A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies</atitle><jtitle>Transplant international</jtitle><addtitle>Transpl Int</addtitle><date>2000</date><risdate>2000</risdate><volume>13 Suppl 1</volume><spage>S78</spage><epage>S81</epage><pages>S78-S81</pages><issn>0934-0874</issn><eissn>1432-2277</eissn><abstract>Renal allograft thrombosis can cause transplant failure. Because antiphospholipid antibodies (aPA) are associated with thrombosis, we investigated pretransplant sera from patients with early renal allograft failure to determine if aPA were present. Fifty-six final cross-match (FxM) sera from patients whose transplant failed within 16 days were compared to FxM sera from the next sequential transplant patients. The sera were tested for IgG, IgM, and IgA antibodies to cardiolipin, phosphatidylserine, and phosphatidylethanolamine. aPA were identified in 57% of FxM sera from patients with early non-function versus 35% of FxM sera from patients with functioning grafts (P = 0.02). Historical sera from 11 aPA-positive patients contained aPA up to 18 months prior to transplantation. Since aPA were present in historical sera, testing for aPA can identify certain patients at risk for early allograft failure. The involvement of aPA in early allograft loss is supported by studies demonstrating aPA recovery from an explanted failed transplant.</abstract><cop>England</cop><pmid>11111967</pmid><doi>10.1007/s001470050280</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0934-0874 |
| ispartof | Transplant international, 2000, Vol.13 Suppl 1, p.S78-S81 |
| issn | 0934-0874 1432-2277 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72472358 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Antibodies, Antiphospholipid - blood Enzyme-Linked Immunosorbent Assay Humans Immunoglobulin A - blood Immunoglobulin G - blood Immunoglobulin M - blood Kidney Transplantation - immunology Kidney Transplantation - physiology Postoperative Period Renal Dialysis Retrospective Studies Risk Factors Treatment Failure Treatment Outcome |
| title | Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T08%3A21%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20early%20renal%20allograft%20failure%20is%20increased%20for%20patients%20with%20antiphospholipid%20antibodies&rft.jtitle=Transplant%20international&rft.au=Wagenknecht,%20D%20R&rft.date=2000&rft.volume=13%20Suppl%201&rft.spage=S78&rft.epage=S81&rft.pages=S78-S81&rft.issn=0934-0874&rft.eissn=1432-2277&rft_id=info:doi/10.1007/s001470050280&rft_dat=%3Cproquest_cross%3E72472358%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72472358&rft_id=info:pmid/11111967&rfr_iscdi=true |